Teladoc, Inc. (the “Company”) announced today that J.P. Morgan
Securities LLC and Deutsche Bank Securities Inc., the lead book-running
managers in the Company’s recent public sale of 9,487,500 shares of
common stock, are releasing a lock-up restriction with respect to
119,991 shares of the Company’s common stock held by an officer of the
Company. The release will take effect on September 24, 2015, and the
shares may be sold on or after such date. All other lock-up restrictions
applicable to holders of the Company’s common stock expire 180 days
after such recent public sale.
This press release is not an offer for sale of the securities in the
United States or in any other jurisdiction where such offer is
prohibited, and such securities may not be offered or sold in the United
States absent registration or an exemption from registration under the
United States Securities Act of 1933, as amended.
About Teladoc
Teladoc, Inc. (NYSE: TDOC) is the nation’s first and largest telehealth
platform, delivering on-demand health care anytime, from almost anywhere
via mobile devices, the internet, secure video and phone. More than 12.5
million U.S. members are connected to Teladoc’s network of over 1,500
board-certified, state-licensed physicians and behavioral health
professionals who provide care for a wide range of non-emergency
conditions. With a median response time of less than 10 minutes, Teladoc
physicians will perform more than 525,000 telehealth visits in 2015.
Teladoc and its physicians consistently earn a 95 percent member
satisfaction rating or better, and Teladoc is the only telehealth
company to be certified by the National Committee for Quality Assurance
(NCQA) for its physician credentialing process.
Recognized by MIT Technology Review as one of its "50
Smartest Companies 2015,” Teladoc works with health plans,
employers, organizations and individuals to provide access to
affordable, high-quality health care on demand. Teladoc is transforming
the access, cost and quality dynamics of health care delivery. For more
information, visit please teladoc.com,
twitter.com/teladoc, facebook.com/teladoc
or linkedin.com/teladoc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150921005372/en/
Copyright Business Wire 2015